NewGenIvf Group Limited (NIVF)
Nasdaq · Healthcare · Medical Care Facilities
$0.11−14.73%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $307K
- 52-week range
- $0.064 – $1,539.00
- 52-week change
- −99.99%
- EPS (trailing)
- $328.32
Fiscal year to Dec 2025
- Revenue
- $4.7M (−13.01%)
- Net income
- $9.9M
- Operating margin
- −226.9%
- Diluted EPS
- $27.36
- Free cash flow
- −$11.1M
From the company’s annual report on SEC EDGAR.
About NewGenIvf Group Limited
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also offers IVF treatment; surrogacy and ancillary caring services, and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company provides its services through clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.
Headquarters: Bangkok, Thailand · 87 employees · nivf.global